Should You Buy Adagio Medical Holdings, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Adagio Medical Holdings, Inc. (ADGM) presents a moderate quality profile with a QOC score of 4.3/10. Trading at $0.52, separating genuine undervalued opportunities from value traps is essential, as detailed by our model data.
The short answer: 1 of 1 CirclFi valuation models project upside for Adagio Medical Holdings, Inc. (ADGM) at $0.52 — the model consensus leans bullish, with a Quality Score of 4.3/10 and Value-Trap risk of 17/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Adagio Medical Holdings, Inc. (ADGM) in 2026?
What Is the Bull Case vs the Bear Case for Adagio Medical Holdings, Inc. (ADGM)?
| Bull case — $1.13 target (+116.9%) | Bear case |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $0.52 and the median fair value of $1.13 implies +116.9% upside potential. | No active model flags significant downside for ADGM. The low Value Trap score paints a constructive picture. |
| According to the CirclFi Deep Alpha Valuation Engine, the PWERM model targets a fair value of $1.13 (+116.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | |
| Industry tailwind: licensing and M&A optionality could provide meaningful support for Adagio Medical Holdings, Inc.'s revenue and margin trajectory in the Medical Devices space. |
How Does ADGM Compare to Its Medical Devices Peers?
Valuation data pages: PMI · POSC · BJDX · NVNO · MODD · AMIX · HAE · GKOS · CV · IRMD · PODD
Which Other Stocks Score Like ADGM on Quality?
Closest companies to ADGM’s Quality of Company score of 4.3/10, across all industries.
- GDST — Chi Special Acquisition Corp. (QOC 4.3) · analysis
- MTWO — M2i Global, Inc. (QOC 4.3) · analysis
- HCMC — Healthier Choices Management Corp. (QOC 4.3) · analysis
- TRNR — Interactive Strength Inc. (QOC 4.3) · analysis
- BYSI — BeyondSpring Inc. (QOC 4.3) · analysis
- ONCO — Onconetix, Inc. (QOC 4.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Devices Screens Does ADGM Appear In?
So Is Adagio Medical Holdings, Inc. (ADGM) Worth Buying in 2026?
Adagio Medical Holdings, Inc. at $0.52 presents what our engine identifies as a high-conviction opportunity: 1 of 1 models see upside, quality stands at 4.3/10, and the median fair value of $1.13 implies +116.9% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. Adagio Medical Holdings, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About ADGM Stock?
Should I buy ADGM stock right now?
Based on CirclFi's multi-model analysis, 1 of 1 models see upside for ADGM at $0.52. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 4.3/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Adagio Medical Holdings, Inc.?
Key risks include: a below-average Quality Score of 4.3/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Devices companies. Always diversify and consult a financial advisor.
How does ADGM compare to its competitors?
Among Medical Devices peers, ADGM holds a Quality Score of 4.3/10. Comparable companies include PMI (QOC 4.4), POSC (QOC 4.3), BJDX (QOC 4.4). The relative ranking helps investors identify whether ADGM offers better fundamental quality than alternatives in the same sector.
Is ADGM a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ADGM's Quality Score of 4.3/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy ADGM at?
CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $1.13 to $1.13. At $0.52, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for ADGM.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad